Rigel Pharmaceuticals (NASDAQ: RIGL ) is a commercial-stage biotechnology company that is developing oral small-molecule kinase inhibitors, which are used to help treat blood disorders and certain cancers. Despite having three commercialized products and marginsMy career in the world of investing began at an early age, fueled by the potential for profits, I first began investing at the age of 11 with the help of my father. I first began picking stocks by looking at what was going to logically make money, an ...